ENTITY
Icure Pharm Inc

Icure Pharm Inc (175250 KS)

22
Analysis
Health Care • South Korea
Icure Pharm. Inc. manufactures and distributes biopharmaceuticals. The Company produces drugs, cosmetics, and other biopharmaceuticals. Icure Pharm markets its products worldwide.
more
bullish•Wonik QnC Corp
•05 Aug 2021 07:44

KOSDAQ150 Index Rebalance Preview: Inclusions Outperforming as Short Sell Ban Helps

Halfway through the review period, we see 15 potential changes to the index. The potential inclusions are outperforming the exclusions as short...

Logo
513 Views
Share
bullish•Wonik QnC Corp
•07 Jun 2021 13:33

KOSDAQ150 Index Rebalance Preview: Lots of Changes Early in the Review Period

A month into the review period for the KOSDAQ150 December rebalance, we can already see 12 potential changes. The potential inclusions should...

Logo
449 Views
Share
•25 May 2021 18:41

KOSDAQ150 Index Rebalance: 16 Changes & Large Turnover

There are 16 changes to the KOSDAQ150 index resulting in a one-way turnover of 7.04%. The impact on the exclusions is a lot higher than on the...

Logo
619 Views
Share
bullish•SK Oceanplant
•25 May 2021 18:31

KOSDAQ 150 Rebalancing Results: Changes, Passive Flow, & Trade Approach

The KRX has just announced the results of the KOSPI 200 semi-annual rebalancing. This post examines the passive flow of the adds and deletes as...

Logo
509 Views
Share
bullish•SIMMTECH Co Ltd
•27 Apr 2021 13:33

KOSDAQ150 Index Rebalance Preview: 15 Potential Changes; Big Impact on Deletions

We see 15 potential changes to the KOSDAQ150 Index at the June review. With short selling resuming on 3 May, the inclusions could outperform the...

Logo
650 Views
Share
x